Statement: BARDA Director on EUA of the Third COVID-19 Vaccine
Alternative Text for Time-Based Media
The following is a text alternative description for the
Statement: BARDA director on emergency use authorization of the third COVID-19 vaccine.
[The video features a statement given by Dr. Gary Disbrow is the Director of the Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services explaining the public-private collaboration and platform technologies brought together for COVID-19 vaccines.]
Dr. Gary Disbrow: The FDA's emergency use authorization of Janssen's COVID-19 vaccine - part of Johnson & Johnson - is exciting news on many fronts. A single dose vaccine stored at refrigerated temperatures... that prevents hospitalizations and deaths from COVID-19, has the potential to change the trajectory of the pandemic in the US and globally.
BARDA has partnered with Janssen since 2015, working together on influenza and an Ebola vaccine. In February of 2020, BARDA and Janssen partnered again to develop a COVID-19 vaccine utilizing the same technology behind their Ebola vaccine that was licensed in the European Union. Janssen has leveraged BARDA's Centers for Innovation in Advanced Development and Manufacturing and our fill-finish manufacturing network - resources we created after the 2009 Influenza pandemic - to manufacture this vaccine in the United States. Through the development of this vaccine, we are seeing the results of years of work on platform technologies and public-private partnerships coming to fruition.
Congratulations to Janssen and the team at the Department of Health and Human Services, BARDA, and our Department of Defense colleagues on the Emergency Use Authorization of their COVID-19 vaccine.
The response to this pandemic continues to be a coordinated response across government and private entities.
Thank you all for your support.
[The video concludes with a non-descript background followed by the Department of Health and Human Services logo, caption and voice-over narrative, “Produced at U.S. taxpayer expense by the U.S. Department of Health and Human Services.”]
